Oncologist Serena Wong, of Rutgers Cancer Institute of New Jersey, reassures patients suffering from cognitive dysfunction, or chemobrain, that they're not alone and there is support.
Oncologist Serena Wong, of Rutgers Cancer Institute of New Jersey, wants to lets patients suffering from cognitive dysfunction, or chemobrain, know that they're not alone.
"It was actually in the 1980s when we were finding that in support groups, a lot of cancer survivors were talking about having trouble with memory, having trouble concentrating. and then people started sharing their experiences," she says. "We started realizing that this is something we needed to pay attention to."
In the 1990s, the scientific community really began studying the issue, she says.
Wong suggests patients be patient with themselves, allow extra time to complete multiple tasks, and understand that going through therapy takes a toll. "You're not going to bounce back immediately, and that can be a little bit frustrating," she says.
She also recommends staying active and exercising to help fatigue, energy and cognitive function.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More